Inventor · disambiguated record
Sylvia Luxen
Also filed as: LUXEN SYLVIA
3 granted patents·2 pending applications·14 citations·filing 2011–2023
65Inventor score
Top patents by PatentIndex Score
5 records- 0193US9718886B2Cancer therapy using CLDN6 target-directed antibodies in vivoSAHIN UGUR·Filed 2011·Granted Aug 1, 2017·13 cites·6 claims
- 0283US2024084033A1Cancer therapy using cldn6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 0377US9902778B2Cancer therapy using CLDN6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS AG·Filed 2016·Granted Feb 27, 2018·1 cites·19 claims
- 0469US2021079113A1Cancer therapy using cldn6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 0564US10844133B2Cancer therapy using CLDN6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS AG·Filed 2018·Granted Nov 24, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Sylvia Luxen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →